GMP Guideline CPMP/QWP/609/96 Rev 1 Note for guidance on Declaration of Storage Conditions for Medicinal Products Particulars and Active Substances (Annex to note for Guidance on Stability Testing of New Active Substances and Medicinal Products, Annex to Note for Guidance on Stability of Existing Active Substances and Related Finished Products) (Date of coming into operation October 2003), Rev 2 withdrawn

Keyword Search in

Contact

Imprint

Site Map

Guideline

The following guideline can be ordered through the address listed in the "Source/Publisher"-category.
In cases in which you can order through the Internet we have established a hyperlink.

CPMP/QWP/609/96 Rev 1 Note for guidance on Declaration of Storage Conditions for Medicinal Products Particulars and Active Substances (Annex to note for Guidance on Stability Testing of New Active Substances and Medicinal Products, Annex to Note for Guidance on Stability of Existing Active Substances and Related Finished Products) (Date of coming into operation October 2003), Rev 2 withdrawn

Short Title: CPMP/QWP/609/96/Rev 1

Internet: http://www.emea.europa.eu/pdfs/human/qwp/060996en.pdf

Origin/Publisher: www.emea.europa.eu

Content: The purpose of this guidance note is to set out uniform statements on storage conditions for inclusion in the labelling of medicinal products and to define when they apply.

Document Type: CPMP/QWP Approved Guideline